Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results. (Q46801197)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2008

Language	Label	Description	Also known as
English	Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results.	scientific article published in March 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: ZO-FAST Study results (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

zoledronic acid

1 reference

based on heuristic

inferred from title

author name string

Nigel J Bundred

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Ian D Campbell

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Neville Davidson

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Richard H DeBoer

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Holger Eidtmann

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Alain Monnier

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Joel C Miller

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Nora L Schenk

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Robert E Coleman

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

0 references

publication date

1 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

112

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1001-1010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18205185%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

21 January 2018

Sex steroids and the construction and conservation of the adult skeleton

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Aromatase and its inhibitors: significance for breast cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Endocrine effects of aromatase inhibitors and inactivators in vivo: review of data and method limitations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone mineral density thresholds for pharmacological intervention to prevent fractures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive Value of BMD for Hip and Other Fractures

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Transmission of human herpesvirus 8 by blood transfusion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality of health care delivered to adults in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term effects of aromatase inhibitors on bone.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

A single intravenous administration of zoledronic acid prevents the bone loss and mechanical compromise induced by aromatase inhibition in rats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Skeletal effects of exemestane on bone-mineral density, bone biomarkers, and fracture incidence in postmenopausal women with early breast cancer participating in the Intergroup Exemestane Study (IES): a randomised controlled study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23259

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46801197&oldid=1775699786"